مصروفات التشغيل تغيير تاريخ
AstraZeneca USD 8.18B 4.35B 2026-03
Bayer EUR 9.88B 452M 2026-03
Essilor EUR 13.09B 1.07B 2025-12
Fresenius EUR 5.25B 337M 2025-12
Fresenius Medical Care EUR 4.34B 63M 2026-03
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GRIFOLS EUR 1.45B 255.28M 2026-03
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.09B 687M 2026-03
Novartis USD 9.29B 507M 2026-03
Philips EUR 3.6B 775M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
Smith & Nephew USD 2.52B 84M 2025-12
Sonova Holding CHF 1.52B 59.9M 2025-12
UCB EUR 2.96B 196M 2025-12